204 related articles for article (PubMed ID: 28481295)
1. Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression.
Li R; Gan YH
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28481295
[TBL] [Abstract][Full Text] [Related]
2. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.
Wei TT; Lin YT; Chen WS; Luo P; Lin YC; Shun CT; Lin YH; Chen JB; Chen NW; Fang JM; Wu MS; Yang KC; Chang LC; Tai KY; Liang JT; Chen CC
EBioMedicine; 2016 Aug; 10():124-36. PubMed ID: 27448759
[TBL] [Abstract][Full Text] [Related]
3. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
4. Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression.
Jang YG; Ko EB; Choi KC
J Nutr Biochem; 2020 Oct; 84():108444. PubMed ID: 32615369
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation.
Chang CC; Huang KH; Hsu SP; Lee YG; Sue YM; Juan SH
Sci Rep; 2019 Mar; 9(1):4606. PubMed ID: 30872677
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach.
Wang L; Chen G; Chen K; Ren Y; Li H; Jiang X; Jia L; Fu S; Li Y; Liu X; Wang S; Yang J; Wu C
Oncotarget; 2015; 6(12):9740-55. PubMed ID: 25762635
[TBL] [Abstract][Full Text] [Related]
7. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
8. Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion.
Kim NH; Kim SN; Kim YK
Biochem Biophys Res Commun; 2011 Jan; 404(4):915-21. PubMed ID: 21184735
[TBL] [Abstract][Full Text] [Related]
9. [Effects of geranylgeranyltransferase Ⅰ gene silencing by RNA interference on the migration and invasion of tongue carcinoma].
Zhenggang C; Shuren W; Jinghua L; Jinhong H; Qimin W; Lei T; Wenjun L; Fang Y; Qingyuan G; Dawei G; Ying W
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Dec; 35(6):576-582. PubMed ID: 29333768
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells.
Maeda A; Yano T; Itoh Y; Kakumori M; Kubota T; Egashira N; Oishi R
Atherosclerosis; 2010 Jan; 208(1):112-8. PubMed ID: 19683239
[TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells.
Gan Y; Wang J; Coselli J; Wang XL
Biochem Biophys Res Commun; 2008 Jan; 365(2):386-92. PubMed ID: 17996726
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin requires geranylgeranyl transferase-I and Rac1 activation to exert neuronal protection and induce plasticity.
Posada-Duque RA; Velasquez-Carvajal D; Eckert GP; Cardona-Gomez GP
Neurochem Int; 2013 Mar; 62(4):433-45. PubMed ID: 23411415
[TBL] [Abstract][Full Text] [Related]
13. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
[TBL] [Abstract][Full Text] [Related]
14. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex.
Chang CC; Sue YM; Yang NJ; Lee YH; Juan SH
PLoS One; 2014; 9(3):e92793. PubMed ID: 24658119
[TBL] [Abstract][Full Text] [Related]
15. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
[TBL] [Abstract][Full Text] [Related]
16. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone.
Johnson TE; Zhang X; Bleicher KB; Dysart G; Loughlin AF; Schaefer WH; Umbenhauer DR
Toxicol Appl Pharmacol; 2004 Nov; 200(3):237-50. PubMed ID: 15504460
[TBL] [Abstract][Full Text] [Related]
17. The effects of different types of statins on proliferation and migration of HGF-induced Human Umbilical Vein Endothelial Cells (HUVECs).
Burgazli KM; Bui KL; Mericliler M; Albayrak AT; Parahuleva M; Erdogan A
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2874-83. PubMed ID: 24254555
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
Al-Haidari AA; Syk I; Thorlacius H
Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
[TBL] [Abstract][Full Text] [Related]
19. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
20. Geranylgeranyltransferase I promotes human glioma cell growth through Rac1 membrane association and activation.
Zhou X; Qian J; Hua L; Shi Q; Liu Z; Xu Y; Sang B; Mo J; Yu R
J Mol Neurosci; 2013 Jan; 49(1):130-9. PubMed ID: 23073905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
